Published in J Investig Dermatol Symp Proc on December 01, 1999
Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest (2007) 1.56
What causes alopecia areata? Exp Dermatol (2013) 1.14
Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol (2004) 1.01
Increased expression of Cxcr3 and its ligands, Cxcl9 and Cxcl10, during the development of alopecia areata in the mouse. J Invest Dermatol (2012) 0.90
Analysis of serum zinc and copper concentrations in hair loss. Ann Dermatol (2013) 0.89
Effects of the Lexington LaserComb on hair regrowth in the C3H/HeJ mouse model of alopecia areata. Lasers Med Sci (2011) 0.89
Macrophages induce AKT/β-catenin-dependent Lgr5(+) stem cell activation and hair follicle regeneration through TNF. Nat Commun (2017) 0.77
The Contributory Roles of Th17 Lymphocyte and Cytotoxic T Lymphocyte at the Hair Bulge Region as Well as the Hair Bulb Area in the Chronic Alopecia Areata Patients. Ann Dermatol (2017) 0.75
Hair Growth-Promoting Effects of Lavender Oil in C57BL/6 Mice. Toxicol Res (2016) 0.75
Hair follicle characteristics as early marker of Type 2 Diabetes. Med Hypotheses (2016) 0.75
Review. Gastroenterol Hepatol (N Y) (2007) 0.75
Possible Relationship between Chronic Telogen Effluvium and Changes in Lead, Cadmium, Zinc, and Iron Total Blood Levels in Females: A Case-Control Study. Int J Trichology (2015) 0.75
A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol (1999) 2.92
The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol (2000) 1.42
Active hair growth (anagen) is associated with angiogenesis. J Invest Dermatol (2000) 1.29
Generation and cyclic remodeling of the hair follicle immune system in mice. J Invest Dermatol (1998) 1.22
Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. J Invest Dermatol (2001) 1.15
Synergistic interaction between the two mechanisms of action of tapentadol in analgesia. J Pharmacol Exp Ther (2011) 1.10
Towards defining the pathogenesis of the hairless phenotype. J Invest Dermatol (1998) 1.06
Patterns of proliferation and apoptosis during murine hair follicle morphogenesis. J Invest Dermatol (2001) 1.02
Chronobiology of the hair follicle: hunting the " hair cycle clock". J Investig Dermatol Symp Proc (1999) 1.00
The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro. Inflamm Res (1999) 0.99
Clusters of perifollicular macrophages in normal murine skin: physiological degeneration of selected hair follicles by programmed organ deletion. J Histochem Cytochem (1998) 0.96
Organization of the Ig VH locus in mice and humans. Immunol Today (1989) 0.91
Contrasting localization of c-Myc with other Myc superfamily transcription factors in the human hair follicle and during the hair growth cycle. J Invest Dermatol (2001) 0.88
New roles for glial cell line-derived neurotrophic factor and neurturin: involvement in hair cycle control. Am J Pathol (2000) 0.87
Isoenzyme-specific cyclooxygenase inhibitors: a whole cell assay system using the human erythroleukemic cell line HEL and the human monocytic cell line Mono Mac 6. J Pharmacol Toxicol Methods (1997) 0.85
[Tapentadol: with two mechanisms of action in one molecule effective against nociceptive and neuropathic pain. Preclinical overview]. Schmerz (2011) 0.83
Burrowing as a non-reflex behavioural readout for analgesic action in a rat model of sub-chronic knee joint inflammation. Eur J Pain (2013) 0.83
Adrenomedullin: expression and possible role in human skin and hair growth. Br J Dermatol (2003) 0.81
Pharmacological validation of a refined burrowing paradigm for prediction of analgesic efficacy in a rat model of sub-chronic knee joint inflammation. Eur J Pain (2013) 0.81
Spontaneous hair follicle cycling may influence the development of murine contact photosensitivity by modulating keratinocyte cytokine production. Cell Immunol (1997) 0.77
Heterogeneous distribution of COX-2 over-expression in human colon carcinoma cells. Adv Exp Med Biol (1997) 0.75
Lack of synergistic interaction between the two mechanisms of action of tapentadol in gastrointestinal transit. Eur J Pain (2014) 0.75
Selective prostaglandin G/H synthase (PGHS)-2 inhibitors show greater inhibitory activities on human PGHS-2 than on murine PGHS-2 in intact cells. Inflammopharmacology (1997) 0.75
Pharmacology of a selective cyclooxygenase-2 inhibitor, HN-56249: a novel compound exhibiting a marked preference for the human enzyme in intact cells. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.75